The Kimberly-Clark/Kenvue transaction is one of the worst-received major merger deals in recent years. Investors wondered why ...

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

Kimberly-Clark is buying Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a massive consumer health ...

Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two ...

The agreement, which combines the maker of Huggies diapers with the owner of the painkiller brand, will create a global ...

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

Kimberly-Clark está comprando al fabricante de Tylenol, Kenvue, en un acuerdo de efectivo y acciones valorado en ...

Mike Hsu aims to stoke the consumer company’s growth by veering into Kenvue’s higher-margin but risky health products.

Kimberly-Clark is making a big move with a nearly $50 billion acquisition. The North Texas company plans to acquire Kenvue ...

The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...